Liver transplantation for acute liver failure related to autochthonous genotype 3 hepatitis E virus infection

Clinics and Research in Hepatology and Gastroenterology

Volumn 38, Issue 1, 2014, Pages 24-31

  Aherfi, Sarah ^a   Borentain, Patrick ^c   Raissouni, Ferdaous ^c   Le Goffic, Aude ^c   Guisset, Michel ^d   Renou, Christophe ^e   Grimaud, Jean Charles ^f   Hardwigsen, Jean ^c   Garcia, Stéphane ^f   Botta Fridlund, Danielle ^c   Nafati, Cyril ^c   Motte, Anne ^a   Le Treut, Yves Patrice ^c   Colson, Philippe ^a,b   Gerolami, René ^c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d Service de pathologie digestive   (France)

^e Centre Hospitalier de Hyères   (France)

^f HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; EUROPE; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 84893962420     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2013.05.013     Document Type: Article

References (43)

1. Kamar N., Bendall R., Legrand-Abravanel F., Xia N.S., Ijaz S., Izopet J., et al. Hepatitis E. Lancet 2012, 379(9835):2477-2488.
2. Purdy M.A., Khudyakov Y.E. The molecular epidemiology of hepatitis E virus infection. Virus Res 2011, 161(1):31-39.
3. Colson P., Romanet P., Moal V., Borentain P., Purgus R., Benezech A., et al. Autochthonous infections with hepatitis E virus genotype 4, France. Emerg Infect Dis 2012, 18(8):1361-1364.
4. Said B., Ijaz S., Kafatos G., Booth L., Thomas H.L., Walsh A., et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009, 15(11):1738-1744.
5. Khuroo M.S. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res 2011, 161(1):3-14.
6. Aggarwal R., Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 2009, 24(9):1484-1493.
7. Patra S., Kumar A., Trivedi S.S., Puri M., Sarin S.K. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007, 147(1):28-33.
8. Dalton H.R., Stableforth W., Thurairajah P., Hazeldine S., Remnarace R., Usama W., et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008, 20(8):784-790.
9. Peron J.M., Mansuy J.M., Poirson H., Bureau C., Dupuis E., Alric L., et al. is an autochthonous disease in industrialized countries. Analysis of 23 patients in South-West France over a 13-month period and comparison with hepatitis A. Gastroenterol Clin Biol 2006, 30(5):757-762.
10. Peron J.M., Bureau C., Poirson H., Mansuy J.M., Alric L., Selves J., et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007, 14(5):298-303.
11. Dalton H.R., Hazeldine S., Banks M., Ijaz S., Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007, 369(9569):1260.
12. Marion-Audibert A.M., Tesse S., Graillot E., Phelip G., Radenne S., Duperret S., et al. Lethal acute HEV superinfection on hepatitis B cirrhosis. Gastroenterol Clin Biol 2010, 34(4-5):334-336.
13. Ijaz S., Arnold E., Banks M., Bendall R.P., Cramp M.E., Cunningham R., et al. Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005, 192(7):1166-1172.
14. Mateos Lindemann M.L., Morales J.G., Fernandez-Barredo S., Dominguez M.R., Garcia de la H.F., Halfon P., et al. Fulminant hepatitis E in a woman taking oral contraceptive medication. Am J Trop Med Hyg 2010, 82(1):12-15.
15. Sallie R., Silva A.E., Purdy M., Smith H., McCaustland K., Tibbs C., et al. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study. J Hepatol 1994, 20(5):580-588.
16. Renou C., Moreau X., Pariente A., Cadranel J.F., Maringe E., Morin T., et al. A national survey of acute hepatitis E in France. Aliment Pharmacol Ther 2008, 27(11):1086-1093.
17. Colson P., Moal V., Motte A., Borentain P., Henry M., Dhiver C et al., 39 PCR-documented cases of acute or chronic hepatitis E over a 2-year period in Marseilles, South-eastern France. Hepatology 2008, 48(S1):1185A-1186A.
18. Panassie L., Borentain P., Nafati C., Bernardin G., Doudier B., Thibault V., et al. Fatal fulminant primary hepatitis B virus infections with G1896A precore viral mutants in southeastern France. Clin Res Hepatol Gastroenterol 2012, 36(1):e1-e8.
19. Colson P., Moal V., Motte A., Gerolami R. Hepatitis E virus as the most frequently identified cause of autochthonous acute hepatitis among adults in Marseille public hospitals. J Hepatol 2011, 54(Suppl. 1):S493-S494.
20. Moal V., Legris T., Burtey S., Morange S., Purgus R., Dussol B., et al. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol 2013, 85(3):462-471.
21. Nicand E., Bigaillon E., Tessé S. Hepatitis E in France: review of cases over a 3 year period, 2006-2008. Bull Epid Hebdo 2009, 31-32:337-342.
22. Colson P., Borentain P., Queyriaux B., Kaba M., Moal V., Gallian P., et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010, 202(6):825-834.
23. Mansuy J.M., Bendall R., Legrand-Abravanel F., Saune K., Miedouge M., Ellis V., et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011, 17(12):2309-2312.
24. Kaba M., Davoust B., Marie J.L., Colson P. Detection of hepatitis E virus in wild boar (Sus scrofa) livers. Vet J 2010, 186(2):259-261.
25. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Garrouste C., Dubois M., Mansuy J.M., et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010, 202(6):835-844.
26. Gisbert J.P., Gonzalez-Lama Y., Mate J. Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review. Am J Gastroenterol 2007, 102(7):1518-1527.
27. Bhatia V., Singhal A., Panda S.K., Acharya S.K. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse?. Hepatology 2008, 48(5):1577-1585.
28. Navaneethan U., Al M.M., Shata M.T. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 2008, 28(9):1190-1199.
29. Labrique A.B., Sikder S.S., Krain L.J., West K.P., Christian P., Rashid M., et al. Hepatitis e, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 2012, 18(9):1401-1404.
30. Takahashi K., Okamoto H., Abe N., Kawakami M., Matsuda H., Mochida S., et al. Virulent strain of hepatitis E virus genotype 3, Japan. Emerg Infect Dis 2009, 15(5):704-709.
31. Inoue J., Takahashi M., Mizuo H., Suzuki K., Aikawa T., Shimosegawa T., et al. Nucleotide substitutions of hepatitis E virus genomes associated with fulminant hepatitis and disease severity. Tohoku J Exp Med 2009, 218(4):279-284.
32. Inoue J., Nishizawa T., Takahashi M., Aikawa T., Mizuo H., Suzuki K., et al. Analysis of the full-length genome of genotype 4 hepatitis E virus isolates from patients with fulminant or acute self-limited hepatitis E. J Med Virol 2006, 78(4):476-484.
33. Mizuo H., Yazaki Y., Sugawara K., Tsuda F., Takahashi M., Nishizawa T., et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol 2005, 76(3):341-349.
34. Purcell R.H., Emerson S.U. Hidden danger: the raw facts about hepatitis E virus. J Infect Dis 2010, 202(6):819-821.
35. Borkakoti J., Hazam R.K., Mohammad A., Kumar A., Kar P. Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy?. J Med Virol 2013, 85(4):620-626.
36. Kar P., Jilani N., Husain S.A., Pasha S.T., Anand R., Rai A., et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy?. Am J Gastroenterol 2008, 103(10):2495-2501.
37. Bose P.D., Das B.C., Kumar A., Gondal R., Kumar D., Kar P. High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome. J Hepatol 2011, 54(6):1107-1113.
38. Saravanabalaji S., Tripathy A.S., Dhoot R.R., Chadha M.S., Kakrani A.L., Arankalle V.A. Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis E. Intervirology 2009, 52(2):78-85.
39. Srivastava R., Aggarwal R., Sachdeva S., Alam M.I., Jameel S., Naik S. Adaptive immune responses during acute uncomplicated and fulminant hepatitis E. J Gastroenterol Hepatol 2011, 26(2):306-311.
40. Kamar N., Rostaing L., Abravanel F., Garrouste C., Lhomme S., Esposito L., et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010, 139(5):1612-1618.
41. Mallet V., Nicand E., Sultanik P., Chakvetadze C., Tesse S., Thervet E., et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010, 153(2):85-89.
42. Peron J.M., Dalton H., Izopet J., Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?. J Hepatol 2011, 54(6):1323-1324.
43. Gerolami R., Borentain P., Raissouni F., Motte A., Solas C., Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011, 52(1):60-62.